Financial informations

The Board of Directors of Ramsay Générale de Santé renews Pascal Roché as Chief Executive Officer

The progressive transformation of Ramsay Santé undertaken by Pascal Roché and all the teams since 2011 has enabled the European leader in health and primary care to face an unprecedented health and economic crisis, to be well positioned to respond to new health challenges and to continue its development on all stages of the patient pathway, in and out of institutions. 

Amendment to the Universal Registration Document 2022

This amendment to the Universal Registration Document was filed on 10 November 2022 with the French Financial Markets Authority (Autorité des Marchés Financiers) as the competent authority under Regulation (EU) 2017/1129, without prior approval in accordance with Article 9 of said regulation.

Ramsay Santé Q1 results at september 30, 2022

9.8% total revenues growth for this quarter, strongly supported by good dynamics in the Nordics countries and recent acquisitions. Growth on a like-for-like basis of 4.9%.

Availability of the Universal Registration Document 2022

Ramsay Générale de Santé's 2022 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) in ESEF (European Single Electronic Format) on Friday 28 October 2022, under number D.22-0786.

Universal Registration Document 2022

Annual results at end June 2022

The solid performance of the Nordic countries has led to an improvement in the results of the Ramsay Santé group, despite the persistent challenges of high inflation, a shortage of nursing and clinical staff and the ongoing pandemic, in which Ramsay Santé has continued to play a leading role in Europe.

Ramsay Santé has concluded an additional €150M loan agreement within its Fiducie Sûreté (created in 2018) becoming one of the largest Fiducies-Sûreté (€318M in cumulative outstandings loan) in the French market and the first one indexed to ESG criteria.

After renegotiating its syndicated debt in April 2021 with a TLB linked to its ESG performance and issuing a Euro PP in December 2021, Ramsay Santé is pursuing its refinancing and sustainable commitment dynamic.

Provisional annual results at end June 2022

Financial results at March 31th : 9 months 2021/2022

Unaudited turnover for the 9 months period ending 31 March 2022 amounted to €3,141.7m, up 6.7% compared to the same period of the previous year. 

Ramsay Santé steps up its ESR strategy with its maiden Euro Private Placement Sustainability-Linked issue

Ramsay Santé pursues its sustainable commitments with the launch of its third financial instrument linked to sustainable development goals.